UCB Pharma Limited

Overview

Legal name

UCB PHARMA LIMITED

Region

South East England

Registered address

208 BATH ROAD

SLOUGH

BERKSHIRE

SL1 3WE

Insolvency history

No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller

1

Company Active LTD

UCB Pharma Limited

CRN 00209905

2

Direct controller Active LTD

Celltech Group Limited

CRN 02159282

3

Ultimate controller Active LTD

UCB (Investments) Limited

CRN 01106309

Company events

Reference milestones and recent Companies House filing stream events.

6 events

26 May

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep

2026

Accounts due

Accounts Due

Next accounts due date

12 May

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2024

Accounts filed

Accounts

Last accounts made up date

22 Oct

2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQ0MDQ0NDQzOGFkaXF6a2N4 | Paper/PDF filed

Published 24 Oct 2024 06:50

24 Nov

1925

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2016

Funded years

2016

Age at first award

90 years

Projects

2016 Feasibility Studies Lead participant

Feasibility study to determine whether a new generation of catalytic antibodies can be made that overcome existing limitations and are suitable for use in a range of clinical settings

1 Jul 2016 to 30 Jun 2017

Awarded

£60,000

Total cost £120,000

Antibodies, produced naturally in our bodies, have been successfully harnessed by the Biopharma industry to provide a whole new range of safe and effective treatments for unmet patient need. A good example is the anti-TNF antibodies, which are now in common use for suffers of rheumatoid arthritis. Most therapeutic antibodies work by binding to a protein r...

Product types

Feasibility Studies